Antibe Therapeutics Inc(Pre-Merger) ATBPF

Why I’m accumulating

[bigmack1]

This next point was made by someone else earlier and it's all we need to think about (IMHO). (Canaccord Upraded the target price to $16.50)........ 

I for one, will not be overthinking this pure and wonderful play. I happily added to my juicy position yesterday and will continue to do so with any significant pullbacks. I won't be shaken in the slightest in my conviction.

It's also nice to know that the company has cash in the bank.

This my friends,  is a pharmaceutical GOLD MINE:)

[WalkOverTheStrt]

I suggest you think about the logic of your statement, the same company that upgrades Antibe turns around and then the same financial firm does the financing. Feels slimy to me. I 'm in Antobe b/c of Wallace, their lead drug results and CMO. Dan IMO is not adept at riases as this one and the last are ill timed and are far too dilutive (why warrants this time if as Dan has stated multiple

[clubhouse19]

About the 16.50 upgrade...really ?    That's  the fox put to guard the chicken coop.

[Actuarial]

So true. While ATE running up from $3.5 to $6 is a leap, it is still far from its full potential - $50? $100? The sky is the limit. GLTA longs!

[3burtc]

This financing closes next week which is SUPER FAST! U.S. pharma partner agreement just around the corner? This will be the Big One! Nuance is great but small compared to what we're heading towards. Glta, up, up,up we go!

[clubhouse19]

It's a bought deal so the closing date is really a moot point. The onus is on the underwriters to sell all their allocated shares preferably by the 24th when they have to hand over the money filled or not !